Sialidosis Info
Understanding Sialidosis, in plain language
A physician-reviewed overview of Type I and Type II Sialidosis — what causes it, what to watch for, and how it’s diagnosed. This page supports, but never replaces, guidance from your medical team.
The Basics
What causes Sialidosis?
Sialidosis is an ultra-rare, inherited lysosomal storage disorder. It’s caused by mutations in the NEU1 gene, which reduces or eliminates activity of the enzyme neuraminidase (sialidase) — leading to a build-up of sugar-linked molecules called sialylated compounds in cells throughout the body.
NEU1, located on chromosome 6, provides instructions for making the enzyme neuraminidase 1.
Neuraminidase normally breaks down sialic acid-containing molecules inside lysosomes, the cell’s recycling centers.
Sialidosis is autosomal recessive — a child must inherit a mutated copy of NEU1 from both parents.
Clinical Types
Type I vs. Type II at a glance
Presentation varies between individuals, even within the same type. This is general orientation, not a diagnostic tool.
Cherry-Red Spot Myoclonus Syndrome
Typically later-onset — late childhood through early adulthood
Congenital, Infantile & Juvenile Forms
Typically earlier-onset — birth through early childhood
Symptoms Overview
Signs that often prompt evaluation
No single symptom confirms Sialidosis — but this combination, especially together, should prompt specialist evaluation.
Sudden, involuntary muscle jerks, often triggered by movement, touch, or startling.
A distinctive red spot on the retina's macula, visible during a dilated eye exam.
Gradually reduced visual acuity, sometimes progressing to significant vision loss over time.
May develop as myoclonus becomes more frequent, particularly in Type I.
Sensorineural hearing loss has been reported, particularly in Type II forms.
More prominent in Type II — thickened facial features that may become apparent over time.
Hepatosplenomegaly (enlarged liver/spleen) is more common in Type II presentations.
Dysostosis multiplex — a pattern of skeletal changes visible on imaging, mainly in Type II.
Getting Answers
The typical diagnostic pathway
Every case is different, and the order below can vary by clinician and geography — but this is the general path most families travel.
Clinical suspicion
A physician notices a pattern of symptoms — often myoclonus and vision changes — that doesn’t fit a more common diagnosis.
Dilated ophthalmologic exam
An eye specialist looks for the characteristic cherry-red macular spot, a strong diagnostic clue.
Enzyme activity assay
A blood or skin sample test measures neuraminidase (sialidase) activity levels.
NEU1 genetic testing
Sequencing confirms the specific NEU1 variant(s), clarifying type and informing family genetic counseling.
Confirmed diagnosis & care planning
A multidisciplinary care team is assembled — typically neurology, ophthalmology, genetics, and physical therapy.
Printable Physician Discussion Guide
A free 2-page PDF with focused questions to bring to appointments, plus a quick Type I vs. Type II reference table.